Learn how Benchling is powering the next generation of antibody R&D

Informa and Benchling discuss why antibody therapeutics are on the rise, and how companies are leveraging Benchling’s technology to handle the complexity of modern antibody R&D.
The video covers:
  • The growing focus on the next generation of immunotherapies 

  • The challenges that these evolving trends pose for immunotherapy and antibody research

  • How Benchling is helping companies transform their data management 

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image